
Primary hypogonadism involves impaired testicular function and usually low testosterone with elevated LH. Secondary hypogonadism involves insufficient hypothalamic or pituitary stimulation, producing low testosterone with low or inappropriately normal LH. FSH, the history, examination, and selected additional tests clarify the cause. Either pattern needs confirmation; the distinction guides treatment and fertility evaluation.12
Key points
- A normal-range LH can be inappropriate when testosterone is low.1
- Secondary describes the location of the problem, not whether it is temporary.1
- Blood testosterone and sperm production require separate assessment.13
What do primary and secondary mean?
Primary hypogonadism means that the testes do not produce enough testosterone despite pituitary stimulation. Secondary hypogonadism means that signaling from the hypothalamus or pituitary is insufficient to support normal testicular output. These are descriptions of the affected level of a feedback system.1
The brain sends gonadotropin-releasing hormone signals to the pituitary, which releases LH and FSH. LH stimulates testosterone production; FSH participates in sperm production. The testes and their hormones feed information back to the upstream system. A disruption at one point changes the pattern at the others.
The terms do not rank severity. Secondary does not mean less important, and primary does not automatically mean incurable. The cause of low testosterone is a separate question that needs the history and additional evaluation.
How do LH and FSH distinguish the patterns?
When testosterone is low, a functioning feedback system should usually increase LH stimulation. A high LH therefore suggests that the testes are underperforming relative to the signal they receive. Low or apparently normal LH can indicate that the upstream response is inadequate.1 2
FSH gives related information about the sperm-producing compartment. LH and FSH need not rise or fall to exactly the same degree, and a single snapshot has limits. A laboratory normal flag means that a value lies within an interval; it does not guarantee that the value is appropriate in relation to the other hormone results.
The LH and FSH guide addresses these combinations. It is the paired interpretation that makes the tests useful. Reading each line of a report in isolation can miss the compensatory signal that points toward the likely location of dysfunction.

What is the practical comparison?
This comparison summarizes typical patterns before treatment. Hormone medicines, acute illness, and mixed disease can complicate them. The table is a guide to questions, not a way to diagnose a person from two numbers.1 2 3
| Feature | Primary pattern | Secondary pattern |
|---|---|---|
| Main location | Testicular response | Hypothalamic or pituitary stimulation |
| Testosterone | Low when androgen deficiency is present | Low when androgen deficiency is present |
| LH | Usually elevated | Low or inappropriately within range |
| FSH | May rise, especially with impaired sperm production | May be low or inappropriately within range |
| Next investigation | Testicular history, examination, selected genetic or reproductive testing | Medication, prolactin, iron, pituitary, and functional causes |
| Reversibility | Depends on the cause | Depends on the cause |
What can produce a primary pattern?
Genetic conditions, previous testicular injury, removal, certain chemotherapy or radiation exposures, and other testicular disorders can reduce production. Pubertal history, undescended testes, fertility history, surgery, and prior cancer treatment provide clues. A clinician may examine testicular size and decide whether a genetic or reproductive assessment is warranted.1
Hormone production and sperm production can be affected differently. A man can have impaired fertility with testosterone within range, or substantial androgen deficiency alongside reproductive impairment. One endpoint does not substitute for the other.
If a primary cause is established, treatment may address androgen deficiency while separate counseling addresses fertility and other consequences of the underlying condition. It would be misleading to assume that a therapy designed to stimulate pituitary signaling can overcome severely impaired testicular response simply because the starting testosterone is low.
What can produce a secondary pattern?
Secondary hypogonadism can follow pituitary or hypothalamic disease, elevated prolactin, iron overload, certain medicines, or congenital signaling disorders. It can also appear with potentially reversible functional suppression related to other health conditions. Similar initial hormone patterns can therefore lead to quite different investigations.1
High prolactin is one example. Some medications raise prolactin; a prolactinoma is another cause. Confirming and explaining the elevation can matter more than immediately replacing testosterone. Pituitary disease can also affect hormones beyond the reproductive axis.4
New headaches, visual changes, evidence of other pituitary hormone deficits, or marked biochemical abnormalities may increase the need for targeted specialist assessment and imaging. Mild low testosterone associated with a plausible functional contributor does not automatically justify the same imaging pathway. The clinical pattern determines the scope.

Is secondary hypogonadism always reversible?
No. Secondary is an anatomical description, while reversible is a prediction about the cause and course. A functional suppression may improve when the contributor changes. A congenital or destructive pituitary condition may require long-term management. A label cannot substitute for evidence of recovery.1
Exogenous androgen use illustrates the problem. It can suppress LH and FSH, followed by low natural testosterone after cessation. In the prospective HAARLEM study, blood testosterone recovery and sperm recovery occurred on different schedules. Most men recovered hormone concentrations earlier than spermatogenesis, and the findings did not guarantee an individual's outcome.5
Calling every secondary pattern temporary can delay investigation; calling every low result permanent can lead to an unnecessary long-term treatment assumption. Follow-up should specify what is expected to change and what repeat measurements would demonstrate recovery.
Can someone have a mixed or compensated pattern?
Yes. More than one part of the system can be affected, so real patients do not always fit a two-column diagram. Chronic disease, prior treatments, and other factors may contribute simultaneously. The initial classification should remain open to revision when additional evidence emerges.1
Another pattern is normal testosterone with elevated LH, sometimes described as compensated testicular dysfunction. The pituitary may be maintaining testosterone through greater stimulation. That finding is not identical to low-testosterone hypogonadism and does not automatically create an indication for replacement.
The appropriate response depends on symptoms, repeat results, history, and whether reproductive or other endocrine concerns are present. This is another reason to preserve the actual numerical results and context rather than relying only on a shorthand label in a problem list.
Documenting the unresolved cause is preferable to forcing a mixed pattern into one category prematurely. The classification should serve the clinical investigation and can change when more reliable measurements or additional findings become available.
Which historical details make the classification more reliable?
The hormone pattern becomes more informative when it is paired with a developmental and treatment history. Relevant details include whether puberty progressed normally, whether the testes were undescended, past surgery or injury, previous cancer treatment, fertility assessments, and family history suggesting a congenital disorder. These details help distinguish a longstanding problem from one acquired later.1
Recent hormone exposure deserves equal attention. A low LH measured during exogenous testosterone use cannot be interpreted as if the person were untreated. A result obtained soon after cessation may reflect ongoing suppression. Without that timeline, a treatment effect can be mistaken for the original disease.
Records also prevent the classification from becoming more certain than the evidence. A referral might appropriately say secondary biochemical pattern with cause under evaluation, rather than announcing a specific pituitary diagnosis. Similarly, high LH can support a primary pattern without identifying a genetic cause.
Preserving this distinction is useful across clinicians. It shows which conclusion rests on measurements, which rests on history, and which remains provisional. Later results can then update the assessment without requiring the patient to defend an early shorthand label that was never a complete diagnosis.
How does the distinction change treatment and fertility decisions?
The distinction helps identify what needs treating and whether the testes may respond to stimulation. It also determines what additional disease should be excluded. Correcting a serum testosterone concentration does not treat every underlying cause or restore every function of the testes.1
Fertility planning needs to happen before exogenous testosterone is selected. The AUA/ASRM infertility guideline advises against prescribing exogenous testosterone to men interested in current or future fertility. A reproductive specialist may consider other approaches based on the actual cause; none should be inferred from an online LH reading alone.3
The diagnostic pathway connects confirmation, classification, and treatment suitability. A complete assessment should explain both the evidence for deficiency and the evidence for its cause, including any uncertainty that remains.
Common questions
Can secondary hypogonadism occur with LH inside the normal range?
Yes. When testosterone is low, LH that does not rise appropriately can be inappropriately normal. The hormones must be interpreted together.1
Does high FSH prove that testosterone is low?
Does everyone with secondary hypogonadism need a pituitary MRI?
References
- 1.Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2018.
- 2.National Library of Medicine. Luteinizing Hormone (LH) Levels Test. MedlinePlus.
- 3.American Urological Association and American Society for Reproductive Medicine. Diagnosis and Treatment of Infertility in Men. Guideline amended 2024.
- 4.Endocrine Society. Hyperprolactinemia. Endocrine Library.
- 5.Smit DL, et al. Disruption and Recovery of Testicular Function During and After Androgen Abuse: The HAARLEM Study. Human Reproduction. 2021.
This article is for general education, not medical advice, diagnosis or a treatment recommendation. A licensed clinician can interpret the evidence in the context of your symptoms, tests, medicines and fertility plans.